|
HS Code |
697929 |
| Name | Vibrio fluvialis |
| Taxonomy | Bacteria |
| Morphology | Gram-negative, curved rod |
| Mobility | Motile with a single polar flagellum |
| Optimal Temperature | 30-37°C |
| Oxygen Requirement | Facultative anaerobe |
| Habitat | Freshwater and estuarine environments |
| Disease Association | Gastroenteritis and wound infections |
| Biochemical Characteristics | Oxidase positive, fermentative metabolism |
| Genome Size | Approximately 4.6 Mb |
| Antibiotic Resistance | Variable, reported resistance to certain drugs |
| First Isolated | 1977 |
As an accredited Vibrio Fluvialis factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Vibrio fluvialis contains 1 mL of bacterial culture in a sealed, labeled sterile vial with safety instructions. |
| Shipping | Vibrio fluvialis is shipped as a regulated biological substance, typically on dry ice in leak-proof, triple-layer packaging to maintain viability and prevent contamination. Shipping complies with IATA/UN3373 or equivalent guidelines, with clear labeling and documentation required. Handling by trained personnel is essential to ensure biosafety during transport. |
| Storage | **Vibrio fluvialis** cultures should be stored in tightly sealed containers, preferably in a biosafety level 2 laboratory. Store stock cultures at -80°C in cryoprotectants for long-term preservation, or at 4°C on agar slants for short-term use. Ensure all containers are clearly labeled and kept away from incompatible substances. Follow appropriate biosafety protocols to prevent contamination or accidental exposure. |
| Purity 99%: Vibrio Fluvialis with Purity 99% is used in clinical diagnostic assays, where it ensures high accuracy in pathogen detection.Cell Density 1x10^8 CFU/mL: Vibrio Fluvialis at Cell Density 1x10^8 CFU/mL is used in microbiology challenge tests, where it provides reliable simulation of environmental contamination.Stability at 4°C: Vibrio Fluvialis with Stability at 4°C is used in laboratory storage conditions, where it maintains cell viability over extended periods.Molecular Weight 2.4 MDa: Vibrio Fluvialis with Molecular Weight 2.4 MDa is used in genomic studies, where it allows precise DNA fingerprinting and strain differentiation.Antibiotic Resistance Profile: Vibrio Fluvialis with characterized Antibiotic Resistance Profile is used in epidemiological surveillance, where it facilitates tracking of antimicrobial resistance patterns.Double Capsule Formation: Vibrio Fluvialis exhibiting Double Capsule Formation is used in virulence mechanism research, where it enables in-depth study of host-pathogen interactions.Serotype O3: Vibrio Fluvialis with Serotype O3 is used in vaccine development trials, where it supports the evaluation of immunogenic response.Growth Rate 0.5 h^-1: Vibrio Fluvialis with Growth Rate 0.5 h^-1 is used in fermentation process optimization, where it leads to efficient biomass yield.Heat Tolerance up to 45°C: Vibrio Fluvialis with Heat Tolerance up to 45°C is used in food safety studies, where it enables assessment of bacterial persistence under thermal stress.Halotolerance 3% NaCl: Vibrio Fluvialis with Halotolerance 3% NaCl is used in marine ecosystem modeling, where it accurately represents saltwater bacterial populations. |
Competitive Vibrio Fluvialis prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day in our laboratories, we encounter tasks that call for accuracy, biological insight, and attention to microbial details. Working hands-on with Vibrio fluvialis, a motile, Gram-negative bacterium, gives us a vantage point few outside direct production experience. This organism holds a distinct place in waterborne disease research, food safety, and the development of antimicrobial solutions. Beneath the microscope, those slender, slightly curved rods tell stories of adaptation, survival, and challenge within aquatic environments and food matrices.
Direct manufacturing of Vibrio fluvialis cultures brings lessons drawn from years of microbial monitoring, repeated fermentations, and detailed analytics. In-house, we ensure precise strain verification and purity—always. Decades of batch experience show that even slight deviations in process control change colony morphology and growth kinetics. Temperature shifts, nutrient selection, and aeration variations play an outsized role in sustaining the stability of this fastidious organism. We tailor bioreactor settings not based on textbook conditions, but on what previous generations of production crews have learned through hundreds of fermentation campaigns. This hands-on approach has reduced failure rates, minimized contamination risks, and strengthened product reliability.
With Vibrio fluvialis, specifications do not end at purity or colony count. Our staff go beyond just delivering viable cells; we check for hemolytic activity, flagella expression, and gene markers linked to virulence, since these impact experimental outcomes. Having the capability to deliver both wild-type and genetically attenuated strains in controlled quantities, we respond to varied research needs, from water testing to epidemiological tracing. We monitor antibiotic resistance profiles closely; recent years have seen an uptick in extensive-drug-resistance markers, and we update documentation for all outgoing lots to track these important trends.
In clinical and diagnostic research, our Vibrio fluvialis cultures support work on diarrheal disease origins and intervention strategies. Labs across the region use our ready-to-inoculate suspensions to calibrate molecular detection assays and validate next-generation sequencing workflows. Public health stakeholders demand reliability and traceability for any bacterial challenge strain. Our team prepares these cultures under certified containment, documents the passage number, and confirms the absence of adventitious agents each cycle. This vigilance ensures that downstream findings—whether in outbreak laboratories, vaccine development, or field trials—rest on firm ground.
Not all Vibrio species react to environmental pressures in the same way. Through persistent side-by-side culturing, our technical staff compares fluvialis to parahaemolyticus, cholerae, vulnificus, and alginolyticus regularly. These comparisons are not just academic; they shape the selection of challenge strains in shelf-life studies and pathogen contamination risk modeling for seafood products. Many contract research clients ask us directly: how does your V. fluvialis differ from a standard parahaemolyticus isolate? Our biologists answer from lived experience—fluvialis tends to demonstrate greater osmotic resilience, slower growth at low temperatures, and unique carbohydrate fermentation patterns. In real-world practice, these differences become visible during cross-reactivity testing with commercial PCR kits or during differential plating on selective agar media.
Fisheries and food production lines where saltwater and brackish water intersect provide fertile terrain for Vibrio fluvialis. Our involvement in food microbiology projects reveals that this organism persists in places overlooked by routine monitoring. Its ability to thrive at moderate salinity and adapt to variable nutrient levels enables it to act as a sentinel organism for hygiene process validation. By supplying this strain directly from our fermenters, quality assurance labs can fine-tune environmental monitoring methods. For instance, we’ve seen a measurable impact in ready-to-eat seafood processing, where Vibrio fluvialis helps stress-test new detection media. Our clients do not want just an organism in a tube—they need extensive support in interpreting growth curve idiosyncrasies, developing false-positive mitigation strategies, and connecting bench data to real-life operational risks.
Our team notes a growing interest in minus-80-degree frozen formats and lyophilized ampoules, rather than classical liquid cultivations. Users want stability for inter-laboratory comparisons and for travel to off-site locations with minimal cold chain support. In response, we invested in pilot-scale freeze dryers and secondary containment packaging, comparing viability rates after multiple freeze–thaw cycles. Batch variation emerges in every manufacturing run, but our staff flag suboptimal post-thaw recoveries immediately, preventing problematic lots from reaching critical projects. Lab veterans still recall early days when cell counts would plummet unpredictably; troubleshooting along the production chain taught us that lot traceability and process control, rather than automation, drive consistency.
Working daily with Vibrio fluvialis means seeing its differences in practical, sometimes frustrating, detail. In our fermentation rooms, this species displays lower halotolerance versus Vibrio vulnificus or parahaemolyticus, requiring closer control of salt gradients in nutrient solutions. Chemically-defined media, successful for many marine isolates, fall short with fluvialis—modification is necessary for robust growth, and our procedure manuals grew thicker as we adapted. Unlike cholerae, which features extensive documentation for each serotype, fluvialis lines are less studied, requiring in-house confirmation of each batch’s phenotypic markers.
Throughout the process, the team documents growth rates at every step, observing that Vibrio fluvialis typically grows more slowly at temperatures below 20°C compared to its relatives. This slower increase in biomass changes the timeline for media changes and harvest windows. We prepared outcome-based training materials reflecting these realities; scientists new to the species often benefit from pilot runs supervised by our most seasoned technicians. In agar plate diagnostics, the typical colony morphologies—the surface sheen, edge texture, and color—strip away guesswork, but only after repeated firsthand exposure. Even after years of hands-on culturing, a sharp eye remains the best defense against mix-ups with similar Vibrio species, especially in high-volume runs.
Reliable production of Vibrio fluvialis underpins efforts to validate rapid detection kits, improve epidemiological tracing, and implement water quality regulations. During flood and storm events, regional public health agencies request fast turnaround on purified Vibrio stocks to simulate real-world contamination in surface water samples. Our manufacturing team often works extended hours during such periods, balancing the need for rapid fulfillment with uncompromised batch integrity. Maintaining correct biosafety documentation and real-time traceability for each shipment requires collaboration between fermentation operators, QA personnel, and shipment coordinators. This operational discipline reflects the value of hands-on experience in keeping pace with shifting public health priorities.
Each year, we receive regular feedback from municipal water authorities confirming the role our cultures play in refining detection strategies. Laboratories use our strains in spiking studies—adding known culture quantities to blind test municipal water—before running these samples through both culture-based and molecular screening. Conversations with public sector microbiologists reveal recurring concerns over false negatives, insufficient strain coverage, and the physical breakdown of live cells in chlorine-treated environments. Our direct engagement with their frontline needs drives our continuous learning, and we routinely test resilience against disinfection agents, cold shock, and starvation conditions to expand the operational relevance of our strains.
Lab customers working in field epidemiology often struggle with strain provenance, genetic drift, and the lack of metadata from legacy suppliers. In response, we have maintained an extensive internal isolate archive, pairing genetic data with full production histories. This transparency enables clients to compare historical and newly acquired strains, supporting continuity in long-term research. Our data management specialists maintain profiles containing allelic types, antimicrobial susceptibilities, and unique phenotypes such as carbohydrate fermentation—all features tracked over dozens of repeat fermentations.
Customization requests often arise from research groups who cross-validate findings in zebrafish, crustaceans, or other aquatic animal models. Providing matched panels of Vibrio fluvialis and related species lets scientists dissect host-pathogen interaction differences. In aquaculture health, researchers rely on our comparator panels to explore outbreak root causes. Each comparative batch involves unique fermentation parameters, reflecting ecological realities rather than theoretical standards. Supporting this depth of inquiry means keeping skilled production talent, up-to-date cold chain logistics, and responsive documentation capabilities—components only found in direct, vertically integrated manufacturing.
Scaling up Vibrio fluvialis production strains typical mid-sized manufacturers to innovate beyond batch reproducibility. As demand increases from labs expanding biobanking, surveillance, and diagnostic validation, we balance tradition with scale-adapted automation. Fermenters handling larger volumes often struggle to sustain even growth; vortex zones cause dead spots, and oxygen gradients lead to variable cell viability. We handle these mechanical challenges by upgrading impeller systems, refining aeration controls, and adding additional real-time cell counting checkpoints along the process. These subtle improvements grew not out of universally accepted standards, but out of repeated troubleshooting and process evolution from real-world setbacks.
Automation brings efficiency, yet it never substitutes for expert oversight when encountering unexpected culture properties. While digital batch records aid traceability, we maintain parallel signed, hand-written logs for critical checkpoints. During unforeseen fermentation stalling or contaminant incidents, a senior microbiologist intervenes, verifying corrective actions and, if necessary, scrapping batches outright. This boots-on-the-ground rigor helps prevent downstream errors that would ripple through the supply chain.
Bringing Vibrio fluvialis from pure isolate to laboratory-ready lots means grappling with more than just batch sizes or colony counts. Operators spend hours checking every vessel, monitoring for shifts in turbidity, pellicle formation, and subtle color changes. Quality assurance hinges on tactile and visual cues. Only those with years at the bench differentiate true growth from artifacts by naked eye inspection. For certain applications—especially in antimicrobial susceptibility testing—the timing of mid-log phase harvests is critical; off-peak harvesting can skew minimum inhibitory concentration outcomes for downstream users. The habit of double-verifying optical density, corroborating with viable cell counts, grew from past incidents where early automation misread particulate dust as live culture.
Shipping presents its own hurdles. Couriers and temperature shifts sometimes disrupt the cold chain. We keep multiple shipping format options ready: solid gel plates, sealed ampoules, or heavily protected cryovials. That redundancy, built into every order, springs from lessons learned during logistical mishaps—like power outages during storms or long-distance shipments held in customs. If a customer needs troubleshooting on a Saturday, lab supervisors can diagnose and respond, drawing from a playbook forged through years of emergency shipments. This accessibility to technical advice sets direct producers apart from secondary vendors and provides irreplaceable value during high-stakes, time-sensitive projects.
Fellow manufacturers understand that each Vibrio fluvialis batch intertwines science, operational discipline, and frontline troubleshooting. Unlike third-party resellers, we observe emerging field trends firsthand. Regulatory shifts, new molecular detection methods, and outbreaks tracked in global news prompt us to refine strain preparation, shipping, and documentation standards. When scientific consensus on diagnostic panels moves forward, our in-house technical team responds by updating reference strain panels with new genetic and phenotypic information. Long-term clients benefit by receiving updates and technical support from those managing direct custodianship of the reference strains, not disinterested middlemen.
The personal connections built over years with field microbiologists, regulators, and industrial researchers create a steady feedback loop. Feedback on lot-to-lot performance, compatibility with new testing technologies, and unforeseen quirks reaches our fermentation rooms rapidly, not filtered through commercial intermediaries. Internal debriefs after significant production campaigns translate field experience into operational improvements that matter to next month’s batches. That’s how our approach avoids the “black box” effect—users know what they’re getting, have access to authentic data, and can speak directly to technical leads who produced their lot from start to finish.
Every year brings demand for greater batch consistency, new molecular markers, and higher flexibility in fulfillment models. The rising tide of environmental monitoring, public health initiatives, and regulatory vigilance has thrown a spotlight on Vibrio fluvialis’ real-world impact. In-house, we invest in training our teams on current emerging regulatory frameworks and detection technologies. As data-driven approaches shape standards for pathogen traceability, our manufacturing workflow adapts—making every lot traceable from source culture to delivery vial. We collaborate on inter-laboratory trials, providing matched batches for reproducibility exercises both domestically and overseas.
As we move further into the digital era, we find more clients asking for full lifecycle metadata, digital imaging, and genetic stamp confirmation. We meet this need with validated sequencing reports, microphotography series, and cross-linked fermentation logs. This information supports not only regulatory submissions but also peer-reviewed publications, method validation, and quality audits. Each manufactured lot, whether destined for disease modeling, diagnostic development, or food safety benchmarking, represents a bridge between foundational microbiology and urgent societal needs.
Producing Vibrio fluvialis at scale is more than a technical achievement—it’s an ongoing dialogue with science, safety, and society. In our experience, only rigorous process transparency, skills retention, and commitment to client support deliver the value expected from a reference culture producer. The knowledge gained over successive manufacturing runs—good and bad—drives continuous refinement.
From the fine-tuning of media recipes in fermenters to the real-world troubleshooting that follows each delivery, we see firsthand how Vibrio fluvialis acts as a vital benchmark organism for diagnostics, food safety, and environmental research. Our work is shaped not just by demand forecasts or regulatory updates, but by the trust laboratory professionals place in direct, expert-led manufacturing. The lessons learned in production find their best outcome not only in packed vials, but in the confidence those vials inspire among researchers working at the frontlines of science and public health.